Paroxysmal nocturnal hemoglobinuria and concurrent JAK2V617F mutation
Open Access
- 23 March 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Blood Cancer Journal
- Vol. 2 (3), e63
- https://doi.org/10.1038/bcj.2012.7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- 3′UTR-truncated Hmga2 cDNA causes MPN-like hematopoiesis by conferring a clonal growth advantage at the level of HSC in miceBlood, 2011
- Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuriaLeukemia, 2010
- Absence of JAK2-V617F in paroxysmal nocturnal haemoglobinuria-associated thrombosisThrombosis and Haemostasis, 2009
- Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH)Blood, 2006
- Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisCancer Cell, 2005
- Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuriaBritish Journal of Haematology, 2001
- Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion.JCI Insight, 1997
- The Cloning of PIG-A, a Component in the Early Step of GPI-Anchor BiosynthesisScience, 1993
- CHARACTERIZATION OF THE HEMATOPOIETIC DEFECT IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA1986
- Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.The Journal of Experimental Medicine, 1984